title: Topical effectiveness of filgrastim in beta-thalassaemia leg ulcer.
authors.forename: N
authors.initials: N
authors.lastname: Stavrianeas
authors.forename: A
authors.initials: A
authors.lastname: Xifteri
authors.forename: D
authors.initials: D
authors.lastname: Kavatha
authors.forename: H
authors.initials: H
authors.lastname: Vrettou
mesh_terms: D000287:Administration, Topical; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D000069585:Filgrastim; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007871:Leg Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects; D017086:beta-Thalassemia / Q000150:complications* / Q000175:diagnosis
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim